Galera Therapeutics Inc (GRTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt GRTX? Forum Prognose

Finanzdaten der Galera Therapeutics Inc-Aktie (GRTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate
Research and Development	19.42% 6.093	7.561	7.272
Interest Income/Expense	147.44% -2.087	4.399	4.223
Operating Income/Loss	20.30% -13.40	-16.81	-13.88
Income/Loss From Continuing Operations Before Tax	27.23% -15.07	-20.71	-17.71
Income/Loss From Continuing Operations After Tax	27.23% -15.07	-20.71	-17.71
Net Income/Loss	27.23% -15.07	-20.71	-17.71
Preferred Stock Dividends And Other Adjustments	-	-	-
Attributable To Noncontrolling Interest	-	-	-
Basic Average Shares	5.97% 45.48	42.92	35.20
Diluted Average Shares	5.97% 45.48	42.92	35.20
Basic Earnings Per Share	31.25% -0.33	-0.48	-0.50
Diluted Earnings Per Share	168.75% -0.33	0.48	-0.50
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-

GMAB

$21.58

1.55%

RPRX

$35.87

1.01%

SMMT

$24.74

7.61%

INSM

$96.47

0.34%

BNTX

$111.78

0.11%

ONC

$255.69

4.59%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Offen in Reuters